The Role of Biomarker Selection Trials in Prostate Cancer

The Role of Biomarker Selection Trials in Prostate Cancer

obr

3 months
101 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
William Oh, MD, Chief of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai elaborates on how biomarker selection trials may help identify in prostate cancer patients.
Up Next Autoplay